By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
MedsparkMedsparkMedspark
  • Home
  • News & Alerts
    News & AlertsShow More
    Medicare’s AI approval pilot drew warnings before it launched
    By
    msadmin
    September 16, 2026
    GE HealthCare’s new AI tools forecast hospital bottlenecks 72 hours out
    By
    msadmin
    September 16, 2026
    Knowtex bets on evaluation science to sell clinical AI to hospitals
    By
    msadmin
    September 16, 2026
    Pediatric heart models now take seconds instead of a workday
    By
    msadmin
    September 16, 2026
    OpenAI Foundation puts $40M behind cancer vaccine data collection
    By
    msadmin
    September 16, 2026
  • Spotlight
    SpotlightShow More
    Robinhood Ventures Fund II brings retail capital to healthcare AI
    By
    msadmin
    August 13, 2026
    Adialante brings accessible MRI-based cancer screening
    By
    msadmin
    August 11, 2026
    CellType models biology so AI can discover drugs
    By
    msadmin
    August 11, 2026
    Healthcare AI startups in Robinhood Ventures Fund II
    By
    msadmin
    August 11, 2026
    OpenAI launches GPT-Rosalind for life sciences research
    By
    msadmin
    July 17, 2026
  • Articles
    ArticlesShow More
    Proteomics model picks breast cancer drugs from biopsies
    By
    msadmin
    September 10, 2026
    CRISP model reads frozen sections to steer cancer surgery
    By
    msadmin
    September 10, 2026
    Consumer chatbots are building a medical system outside hospitals
    By
    msadmin
    August 21, 2026
    Reasoning gaps hold back AI agents in scientific discovery
    By
    msadmin
    August 11, 2026
    Benchmark scores can’t track real clinical LLM use, Stanford says
    By
    msadmin
    August 11, 2026
  • About
    • Mission
    • Services
    • Contact
  • Shop
    • All Items
    • By Category
    • Cart
  • Newsletter
Font ResizerAa
MedsparkMedspark
Font ResizerAa
  • Home
  • News & Alerts
  • Spotlight
  • Articles
  • About
  • Shop
  • Newsletter
  • Home
  • News & Alerts
  • Spotlight
  • Articles
  • About
    • Mission
    • Services
    • Contact
  • Shop
    • All Items
    • By Category
    • Cart
  • Newsletter
Follow US
Spotlight

Global Study Finds Trust and Demographics Key to Patient Acceptance of AI in Healthcare

A multinational study reveals that while most patients support AI in medicine, trust, health status, and tech familiarity significantly shape their views.

Yu Chi Huang
By
Yu Chi Huang
Yu Chi Huang
ByYu Chi Huang
Yu Chi is a senior regulatory affairs specialist and medical researcher focusing on medical devices.
Published: June 10, 2025
Share
2 Min Read
SHARE

As first reported by Inside Precision Medicine, a groundbreaking study involving over 13,800 patients across 43 countries found broad support for the use of AI in healthcare—but also uncovered striking variations in acceptance based on demographics, health status, and technological literacy.

Led by researchers from the Technical University of Munich and published in JAMA Network Open, the survey is the most comprehensive global analysis of patient perspectives on AI in medicine to date. The results underscore the critical need to tailor AI implementation to the unique preferences and concerns of different populations.

Source: mh.tum.de.

The study revealed that women, individuals in poorer health, and those with lower digital literacy were less enthusiastic about AI integration in healthcare. While 57.6% of all participants had a positive view of medical AI, only 55.6% of women and just 29.2% of patients in poor health expressed favorable attitudes—compared to 59.1% of men and 94.7% of those in very good health.

In contrast, those with greater exposure to and understanding of technology demonstrated significantly higher trust levels in AI’s role, especially in areas like diagnosis and risk prediction. Still, fewer than half of respondents expressed full trust in AI-driven treatment guidance.

Notably, over 70% of patients preferred AI systems that offered clear explanations and supported, rather than replaced, physician-led decisions—even if it meant sacrificing some degree of accuracy. Many also voiced concerns around data privacy, decreased personal interaction with doctors, and the potential for rising costs.

These insights emphasize that successful AI adoption in healthcare must be as much about building trust and clarity as it is about innovation and accuracy—making patient-centric design and communication essential in future developments.

SOURCES:TUM School of Medicine and Health
VIA:Inside Precision Medicine
Share This Article
Facebook Copy Link Print
Yu Chi Huang
ByYu Chi Huang
Yu Chi is a senior regulatory affairs specialist and medical researcher focusing on medical devices.

You Might Also Like

News & AlertsSpotlight

Sage Healthspan Launches AI-Powered Precision Health App With Privacy-First Design

By
Yu Chi Huang
June 27, 2025
News & AlertsSpotlight

UK Expands MHRA’s AI Airlock Programme With £1M Boost to Fast-Track Safe AI Medical Devices

By
Yu Chi Huang
June 23, 2025
Spotlight

CellType models biology so AI can discover drugs

By
msadmin
August 11, 2026
Spotlight

Robinhood Ventures Fund II brings retail capital to healthcare AI

By
msadmin
August 13, 2026

AI news, analysis, and insights for healthcare, biotech, and pharma.

Facebook Twitter Youtube Linkedin
Quick Links
  • News & Alerts
  • Articles
  • Spotlight
  • Events
About Medspark
  • Mission
  • Services
  • Contact

© Copyright 2026 MedSpark. All rights reserved.

Privacy Policy | Legal